Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: a phase II trial-Reference-Cited by-同舟云学术

Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: a phase II trial

Published:2009-01 Issue:2 Volume:50 Page:216-222
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Blanes Margarita,de la Rubia Javier,Lahuerta Juan J.,González José D.,Ribas Paz,Solano Carlos,Alegre Adrián,Sanz Miguel A.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190802630170

Reference32 articles.

1. A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

2. High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

3. Stem-cell transplantation in multiple myeloma

4. Five decades of therapy for multiple myeloma: a paradigm for therapeutic models

5. Long-term follow-up after high-dose therapy for high-risk multiple myeloma

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial;Bone Marrow Transplantation;2022-04-20

2. Long-term outcomes of busulfan plus melphalan-based versus melphalan 200 mg/m2 conditioning regimens for autologous hematopoietic stem cell transplantation in patients with multiple myeloma: a systematic review and meta-analysis;Cancer Cell International;2021-11-10

3. Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma;Annals of Hematology;2019-03-16

4. Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150);Biology of Blood and Marrow Transplantation;2018-05

5. High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma;Bone Marrow Transplantation;2017-10-30